Monoclonal IgG as antigens: Reduction is an early intracellular event of their processing by antigen-presenting cells

International Immunology

Volumn 8, Issue 2, 1996, Pages 211-219

  Santoro, Lyse ^a   Reboul, Angeline ^a   Kerblat, Isabelle ^a   Drouet, Christian ^a   Colomb, Maurice G ^a  

^a INSERM   (France)

Author keywords

Antigen; IgG; Partial reduction; Presentation; Processing

Indexed keywords

ANTIGEN; CD4 ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN KAPPA CHAIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; PARAPROTEIN;

AMINO ACID SEQUENCE; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; INTERNALIZATION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS CELL TRANSFORMATION;

ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; B-LYMPHOCYTES; CELL LINE, TRANSFORMED; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN KAPPA-CHAINS; INTRACELLULAR FLUID; LYMPHOMA, LARGE-CELL; OXIDATION-REDUCTION; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0030060413     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/8.2.211     Document Type: Article

References (49)

1. Mach, J -P., Pèlegrin, A. and Buchegger, F. 1991 Imaging and therapy with monoclonal antibodies in non-hematopoietic tumors. Curr Opin Immunol. 3:685
2. Pietersz, G A. and McKenzie, I. F. C. 1992. Antibody conjugates for the treatment of cancer Immunol Rev 129:57.
3. Lanzavecchia, A., Abrignani, S., Scheidegger, D., Obrist, R., Dörken, B. and Moldenhauer, G. 1988. Antibodies as antigens. The use of mouse monoclonal antibodies to focus human T cells against selected targets J. Exp. Med. 167:345.
4. Kosmas, C., Epenetos, A A. and Courtenay-Luck, N. S. 1991. Patients receiving murine monoclonal antibody therapy for malignancy develop T cells that proliferate in vitro in response to these antibodies as antigens. Br. J. Cancer 64:494.
5. Madden, D. R. and Wiley, D. C. 1992. Peptide binding to the major histocompatiblity complex molecules. Curr. Opin. Struc. Biol. 2:1411
6. Brown, J H , Jardetzky, T. S., Gorga, J. C., Stern, L. J , Urban, R. G., Strominger, J. L. and Wiley, D. C 1993. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364:33.
7. Neefjes, J J and Momburg, F 1993. Cell biology of antigen presentation. Curr Opin Immunol 5:27.
8. Rammensee, H.-G., Falk, K. and Rötzschke, O. 1993. MHC molecules as peptide receptors. Curr. Opin. Immunol 5:35.
9. Amigorena, S., Drake, J. R., Webster, P. and Meliman, I 1994. Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes. Nature 369:113.
10. Tulp, A., Verwoerd, D., Dobberstein, B , Ploegh, H. L. and Pieters, J. 1994. Isolation and characterization of the intracellular MHC class II compartment. Nature 369:120
11. West, M. A., Lucocq, J. M. and Watts, C. 1994. Antigen processing and class II MHC peptide-loading compartments in human B-lymphoblastoid cells. Nature 369:147.
12. Harford, J., Bridges, K., Ashwell, G and Klausner, R. D. 1983. Intracellular dissociation of receptor-bound asialoglycoproteins in cultured hepatocytes. J. Biol. Chem. 258:3191.
13. Kurlander, J. R. and Gartrell, J. E 1983 The binding and processing of monoclonal human IgG1 by cells of a human macrophage-like cell line (U937). Blood 62:652
14. Mellman, I. and Plutner, H. 1984 Internalization and degradation of macrophages Fc receptors bound to polyvalent immune complexes J. Cell Biol. 98:1170.
15. Mellman, I , Plutner, H. and Ukkonen, P 1984. Internalization and rapid recycling of macrophage Fc receptors tagged with monovalent antireceptor antibody possible role of a prelysosomal compartment. J. Cell Biol. 98:1163.
16. Amigorena, S., Bonnerot, C., Drake, J. R , Choquet, D., Hunziker, W., Guillet, J.-G., Webster, P, Sautes, C., Mellman, I. and Fridman, W. H. 1992. Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes. Science 256:1808
17. Bonnerot, C and Fridman, H. 1993. Bases moléculaires de la diversité fonctionnelle des récepteurs des anticorps. Médecine/Sciences 9:1236.
18. Régnier-Vigouroux, A , El Ayeb, M , Defendini, M -L., Gragnier. C and Pierres, M. 1988 Processing by accessory cells for presentation to murine T cells of apamin, a disulfide-bonded 18 amino acid peptide. J. Immunol. 140:1069.
19. Collins, D S., Unanue, E R. and Harding, C. V. 1991. Reduction of disulfide bonds within lysosomes is a key step in antigen processing. J Immuol 147:4054
20. Jensen, P E 1993 Acidification and disulfide reduction can be sufficient to allow intact proteins to bind class II MHC. J Immunol 150:3347.
21. Maillère, B., Cotton, J., Mourier, G , Léonetti, M., Leroy, S. and Ménez, A 1993. Role of thiols in the presentation of a snake toxin to murine T cells. J. Immunol. 150:5270
22. Buus, S. and Werdelin, O. 1986. A group-specific inhibitor of lysosomal cysteine proteinases selectively inhibits both proteolytic degradation and presentation of the antigen dinitrophenyl-poly-L-lysine by guinea pig accessory cells to T cells. J. Immunol 136:452
23. Puri, J. and Factorovich, Y 1988. Selective inhibition of antigen presentation to cloned T cells by protease inhibitors. J Immunol. 141:3313.
24. Takahashi, H., Cease, K. B. and Berzofsky, J. A. 1989 Identification of proteases that process distinct epitopes on the same protein. J. Immunol 142:2221.
25. Diment, S 1990. Different roles for thiol and aspartyl proteases in antigen presentation of ovalbumin. J. Immunol. 145:417
26. Van Noort, J M., Boon, J., Van der Drift, A. C. M., Wagenaar, J P. A., Boots, A. M. H. and Boog, C. J. P 1991 Antigen processing by endosomal proteases determines which sites of sperm-whale myoglobin are eventually recognized by T cells Eur J Immunol 21:1989
27. Bond, J. S. and Butler, P E. 1987. Intracellular proteases. Annu Rev. Biochem 56:333
28. Guagliardi, L. E., Koppelman, B., Blum, J. S., Marks, M. S., Creswell, P. and Brodsky, F. M 1990 Co-localization of molecules involved in antigen processing and presentation in an early endocytic compartment. Nature 343:133.
29. Bennett, K., Levine, T., Ellis, J. S , Peanasky, R. J., Samloff, I. M., Kay, J and Chain, B. M 1992. Antigen processing for presentation by class II major histocompatibility complex requires cleavage by cathepsin E. Eur. J. Immunol. 22:1519.
30. Matsunaga, Y., Saibara, T., Kido, H. and Katunuma, N. 1993 Participation of cathepsin B in processing of antigen presentation to MHC class II FEBS Lett 324:325.
31. Rodriguez, G M. and Diment, S. 1992. Role of cathepsin D in antigen presentation of ovalbumin. J. Immunol. 149.2894.
32. Kominami, E , Ueno, T , Muno, D and Katunuma, N 1991. The selective role of cathepsins B and D in the lysosomal degradation of endogenous and exogenous proteins. FEBS Lett. 287 189
33. Gradehandt, G. and Ruede, E 1991 The endo/lysosomal protease cathepsin B is able to process conalbumin fragments for presentation to T cells. Immunology 74.393
34. Santoro, L., Drouet, C , Reboul, A., Mach, J.-P. and Colomb, M. G. 1994. Covalent binding of C3b to monoclonal antibodies selectively up-regulates heavy chain epitope recognition by T cells. Eur J Immunol. 24:1620.
35. 131Ilabelled monoclonal anti-CEA antibodies in a nude mouse model. Int J Cancer 41.127.
36. Porath, J. and Ui, N. 1964. Chemical studies on immunoglobulins in a new preparative procedure for γ-globulins employing glycine-rich solvent systems. Biochim. Biophys. Acta 90:324.
37. Salacinski, P. R. P , McLean, C , Sykes, J. E. C., Clement-Jones, V. V. and Lowry, P J 1981. Iodination of proteins, glycoproteins and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3α,6α-diphenyl glycoluril (lodogen) Anal. Biochem 117:136.
38. Penefsky, H. S. 1977 Reversible binding of Pi by beef heart mitochondrial adenosine triphosphatase J. Biol Chem. 252 2891.
39. Aman, P., Ehlin-Henriksson, B and Klein, G 1984 Epstein-Barr virus susceptibility of normal B lymphocyte populations J. Exp. Med 159:208.
40. Good, M. F., Quakyi, I. A., Saul, A , Berzofsky, J A., Carter, R. and Miller, L. H. 1987. Human T clones reactive to the sexual stages of Plasmodium falciparum malaria. High frequency of gamete-reactive T cells in peripheral blood from nonexposed donors J Immunol. 138.306.
41. Laemmli, U K 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227:680.
42. Landegren, U. 1984. Measurement of cell numbers by means of the endogenous enzyme hexosaminidase Applications to detection of lymphokines and cell surface antigens J Immunol Methods 67.379.
43. Donermeyer, D L. and Allen, P M. 1989. Binding to la protects an immunogenic peptide from proteolytic degradation. J. Immunol. 142.1063.
44. Maison, C. M., Villiers, C. L. and Colomb, M G. 1989. Secretion, cleavage and binding of complement component C3 by human monocytic cell line U937. Biochem. J. 261:407.
45. Lloyd, J. B. 1986. Disulphide reduction in lysosomes. The role of cysteine. Biochem. J. 237:271.
46. Pisoni, R. L., Acker, T. L , Lisowski, K. M., Lemons, R M. and Thoene, J G. 1990. A cysteine-specific lysosomal transport system provides a major route for the delivery of thiol to human fibroblast lysosomes: possible role in supporting lysosomal proteolysis. J. Cell. Biol. 110:327.
47. Holmgren, A. 1989. Thioredoxin and glutaredoxin systems. J. Biol. Chem. 264:13963
48. Santoro, L., Reboul, A., Journet, A M. and Colomb, M. G. 1993. Major involvement of cathepsin B in the intracellular proteolytic processing of exogenous IgGs in U937 cells. Mol. Immunol. 30 1033
49. Sette, A., Adorini, L., Colon, S. M., Buus, S and Grey, H. M. 1989. Capacity of intact proteins to bind to MHC class II molecules J. Immunol. 143:1265.